ATE532064T1 - Genmarker und dessen verwendung - Google Patents

Genmarker und dessen verwendung

Info

Publication number
ATE532064T1
ATE532064T1 AT06702618T AT06702618T ATE532064T1 AT E532064 T1 ATE532064 T1 AT E532064T1 AT 06702618 T AT06702618 T AT 06702618T AT 06702618 T AT06702618 T AT 06702618T AT E532064 T1 ATE532064 T1 AT E532064T1
Authority
AT
Austria
Prior art keywords
immunosuppressive agent
rejection
immunological tolerance
efficacy
absence
Prior art date
Application number
AT06702618T
Other languages
English (en)
Inventor
Yusuke Tanigawara
Maiko Nomoto
Kiyoshi Mihara
Osamu Iketani
Minoru Tanabe
Ken Hoshino
Motohide Shimazu
Yasuhide Morikawa
Original Assignee
Univ Keio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Keio filed Critical Univ Keio
Application granted granted Critical
Publication of ATE532064T1 publication Critical patent/ATE532064T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT06702618T 2005-01-13 2006-01-13 Genmarker und dessen verwendung ATE532064T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005006728 2005-01-13
JP2006000336 2006-01-13

Publications (1)

Publication Number Publication Date
ATE532064T1 true ATE532064T1 (de) 2011-11-15

Family

ID=40789099

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06702618T ATE532064T1 (de) 2005-01-13 2006-01-13 Genmarker und dessen verwendung

Country Status (2)

Country Link
US (1) US20090162868A1 (de)
AT (1) ATE532064T1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2752766C1 (ru) * 2020-11-10 2021-08-03 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Способ определения иммунологической толерантности у животных

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same

Also Published As

Publication number Publication date
US20090162868A1 (en) 2009-06-25

Similar Documents

Publication Publication Date Title
NZ592358A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure using tissue inhibitor of metalloproteinase 2 (timp-2)
NZ701807A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ATE534911T1 (de) Verfahren zur diagnostizierung einer entzündlichen darmerkrankung
IL183872A0 (en) Determination of neutrophil gelatinase-associated lipocalin (ngal) as a diagnostic marker for renal disorders
WO2012024255A3 (en) Camkk-beta as a target for treating cancer
MX2015006680A (es) Composiciones y metodos para diagnosticar tumores de tiroides.
HK1149956A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
NZ591437A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
DE602006021038D1 (de) Verfahren zur diagnose eines ovarialkarzinoms
IN2014DN04226A (de)
BR112013000869A2 (pt) método para diagnóstico de câncer de próstata (pca) com uma sensibilidade desejada em um sujeito; método para monitorar a progressão do câncer de próstata (pca) em um sujeito; método para avaliar se um sujeito tem que ser submetido a uma biópsia de próstata; kit compreendendo um primeiro componente e, opcionalmente, um segundo componente e uso de um kit
MX2010007106A (es) Sistemas y metodos para el analisis de datos de pozos.
IN2013CN01129A (de)
WO2008091814A3 (en) Assessment of asthma and allergen-dependent gene expression
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
EA200801046A1 (ru) Неинвазивный способ выявления переходно-клеточной карциномы мочевого пузыря in vitro
MY162697A (en) Methods, devices and kits for detecting or monitoring acute kidney injury
WO2006001931A3 (en) Prouroguanylin as therapeutic and diagnostic agents
HK1133295A1 (en) Use of protein s100a12 as a marker for colorectal cancer s100a12
ATE456801T1 (de) Verfahren zur messung immunsuppressiver tacrolimus-, sirolimus- und cyclosporin-a- komplexe in einer blutprobe
WO2005121366A8 (ja) 遺伝子マーカー及びその利用
MX2009012531A (es) Metodos y composiciones para identificar y tratar lupus.
WO2009149319A3 (en) Gene expression profiles associated with asthma exacerbation attacks
RU2014105558A (ru) Диагностика болезни альцгеймера